Clinical value of therapeutic drug monitoring for levetiracetam in pediatric patients with epilepsy
Open Access
- 8 February 2023
- journal article
- research article
- Published by Elsevier in Brain and Development
- Vol. 45 (5) , 285-292
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Research Foundation for Clinical Pharmacology
This publication has 22 references indexed in Scilit:
- Influence of enzyme inducing antiepileptic drugs on the pharmacokinetics of levetiracetam in patients with epilepsyEpilepsy Research, 2011
- Age and Comedications Influence Levetiracetam Pharmacokinetics in ChildrenPediatric Neurology, 2010
- Simultaneous determination of Levetiracetam and its acid metabolite (ucb L057) in serum/plasma by liquid chromatography tandem mass spectrometryClinical Biochemistry, 2010
- Retrospective Population Pharmacokinetic Analysis of Levetiracetam in Children and??Adolescents with EpilepsyClinical Pharmacokinetics, 2008
- Pharmacokinetics of Levetiracetam in Infants and Young Children with EpilepsyEpilepsia, 2007
- Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproateEpilepsy Research, 2007
- Ontogeny of drug elimination by the human kidneyPediatric Nephrology, 2005
- Levetiracetam Therapeutic Monitoring in Patients with EpilepsyTherapeutic Drug Monitoring, 2004
- Serum Concentrations of Levetiracetam in Epileptic Patients: The Influence of Dose and Co-medicationTherapeutic Drug Monitoring, 2003
- Pharmacokinetic profile of levetiracetamPharmacology & Therapeutics, 2000